Exelon (EXC) Q1 2026 Earnings Transcript

Exelon reported Q1 adjusted operating earnings of $0.91 per share, slightly below $0.92 a year ago but ahead of expectations, and reaffirmed full-year guidance of $2.81 to $2.91 per share. Management also maintained its 2025-2029 growth outlook near the top end of 5%-7%, while shifting $1.1 billion of capital from distribution to transmission and targeting $350 million of incremental O&M savings in 2027. The call was dominated by regulatory changes in Pennsylvania and Maryland, including PICO withdrawing recent rate cases and Pepco Maryland seeking a $119.9 million revenue requirement.

Analysis

The key market signal here is not the earnings print; it is management’s willingness to sacrifice near-term distribution growth to protect the compounding engine in transmission. That reallocation is structurally better for equity durability because transmission has higher visibility, longer duration, and a cleaner inflation pass-through than distribution in the current political climate. In practice, this should compress perceived earnings risk over the next 12-24 months even if headline growth looks flatter, because the company is swapping regulatory sensitivity for contract-like infrastructure returns.

The bigger second-order effect is on credit and equity funding. By pre-funding a meaningful slice of the equity and debt stack, management is reducing the classic utility “financing overhang” that usually caps multiples when rates rise and capex accelerates. That said, the Pennsylvania retreat is a warning that affordability politics can now override normal utility ratemaking cadence; if other jurisdictions copy that posture, the market may eventually discount the stated 5%-7% growth target as too dependent on policy goodwill.

The most underappreciated bull case is that load growth is forcing a capex mix shift toward transmission just as competitors face queue, permitting, and interconnection bottlenecks. That means Exelon can benefit from scarcity rents without bearing the full merchant power risk, and the real constraint becomes execution and regulatory approval rather than demand. The main bear case is not earnings miss risk in 2026; it is that repeated affordability concessions and lower allowed returns could pressure longer-dated ROE assumptions and eventually re-rate the stock below traditional regulated-utility premiums.

Near term, the stock likely trades better on the de-risking of guidance and financing than on the Pennsylvania headlines. Over the next 3-6 months, any upside surprise will likely come from transmission awards, Maryland/Delaware rate-case outcomes, or a softer credit tone if agencies view the capital reshuffle as disciplined rather than defensive.

Key Decisions for Investors

• Long EXC on a 3-6 month horizon: use pullbacks tied to Pennsylvania/regulatory noise as entry points; risk/reward favors a 10-15% upside rerating if transmission wins and credit concerns stay contained.
• Sell downside in EXC via 3-6 month put spreads instead of outright long stock if you want income: the company has reduced near-term balance-sheet risk, so implied vol should overstate event risk unless a negative regulatory surprise emerges.
• Pair trade: long EXC / short a higher-distribution-sensitivity regulated utility with more exposed state ROE risk over the next 6-12 months; EXC is better positioned if the market starts pricing policy-driven capital repricing across utilities.
• Add to EXC only after Maryland order timing is known in August and MISO bid outcomes are clearer; those are the next catalysts that can validate the capital shift and support a multiple expansion.
• Avoid chasing the name if long-duration rates spike materially; EXC still depends on funding markets, so a move higher in real yields would likely offset much of the operational de-risking.